You are here

Mapi Pharma

Viatris' launch plans scuttled as FDA rebuffs long-acting MS drug from partner Mapi

Fierce Pharma

Mon, 03/11/24 - 11:32 am

multiple sclerosis

glatiramer acetate depot

Mylan and Mapi Pharma Partner on Once Monthly Glatiramer Acetate Drug for Relapsing-Remitting MS

CP Wire

Tue, 04/10/18 - 11:24 am

Relapsing Remitting Multiple Sclerosis

Biotech Rival to Teva Blockbuster Said to Seek IPO

Bloomberg

Sun, 03/23/14 - 10:08 am

Teva Pharmaceuticals